Finding 498500 (2023-003)

Material Weakness Repeat Finding
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-09-26

AI Summary

  • Core Issue: The Academy failed to submit the data collection form on time, breaching federal reporting requirements.
  • Impacted Requirements: This noncompliance relates to the Uniform Grant Guidance, which mandates submission within 30 days of the audit report or nine months post-audit period.
  • Recommended Follow-Up: The Academy should strengthen internal controls to ensure timely submissions of federal reports to avoid future issues.

Finding Text

Section III. Findings and Questioned Costs for Federal Awards Other Matter - Noncompliance/Material Weakness Finding 2023-003: Timely Submission of the Data Collection Form Research and Development Cluster (93.279) Agency and Award: Department of Health and Human Services: National Institutes of Health Drug Abuse and Addiction Research Programs for Assistance Listing Number 93.279 Criteria: Under the Uniform Grant Guidance, Section 200.512, Report Submission, the audit must be completed and the data collection form must be submitted within the earlier of 30 days of the auditor’s report or nine months after the end of the audit period. Condition: The Academy’s 2022 data collection form was not submitted within nine months after the end of the audit period. Cause: The audit was not able to be completed before the deadline due to the material weakness noted in Finding 2023-001. Effect: Non-timely electronic submission of federal reporting package represents noncompliance with regulations, which could have implications on federal funding. Context: The Academy did not have a proper set of internal controls in place to report timely. Questioned costs: None reported Repeat Finding: Yes, a finding in 2022, 2022-003 and in 2021, 2021-002. Recommendation: We recommend the Academy ensure its controls over timely electronic submission of federal report package is effective. Views of responsible officials and planned corrective actions: The Academy agrees with the finding. See corrective action plan.

Categories

Material Weakness Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

  • 498499 2023-003
    Material Weakness Repeat
  • 1074941 2023-003
    Material Weakness Repeat
  • 1074942 2023-003
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.279 Drug Abuse and Addiction Research Programs $661,179